Congratulations to the 2024 Innovator or Innovation Team of the Year finalists

​

​​Genomic Autopsy Study

Professor Hamish Scott, Professor Christopher Barnett, Dr Matilda Jackson, Dr Thuong Ha, Dr Nick Manton.

​

SA Pathology, Department of Genetics and Molecular Pathology, Centre for Cancer Biology.

​

Pregnancy loss at any time during gestation is deeply distressing for expectant parents, and often occurs without a cause being identified. Despite scientific and medical advances, the rate of pregnancy loss has not declined in Australia over the past 20 years.  

 

The Genomic Autopsy Study is a national research study based in Adelaide, South Australia that aims to better understand the underlying causes of pregnancy loss, with the hope of providing families with answers and reproductive options to avoid future recurrence.  

 

To date, the genomic data from 406 families affected by pregnancy loss has been analysed, with a likely or possible answer for the loss provided to parents in just under half of all these cases. The Genomic Autopsy Study offers diagnostic testing with short turnaround times for direct clinical impact.  

 

This research aims to make a significant contribution towards reducing the rate of pregnancy loss and to inform public health policy recommendations, which will have significantly broader socioeconomic implications.

​

Museum of Discovery (MOD.)

Dr Kristin Alford, Dr Lisa Bailey, Mr Daniel Lawrance, Dr Dylan DeLosAngeles, Ms Claudia von der Borch.

​

University of South Australia

​

Building science and futures literacy is critical to developing skill capability, capacity and diversity in young people in order to meet the demands of growth in STEM and technology-based industries.

​

MOD. is Australia’s leading future-focused museum and a principal innovator among emerging future-oriented museums. Since opening to the public in 2018, MOD. has held 12 exhibitions, welcomed over 340,000 visitors and 500 schools, and been nationally and globally recognised through multiple awards.

​

MOD. designs exhibitions for a 15-25 year old audience, who traditionally are amiss in the museum sector’s focus, and uniquely places MOD. as a key actor with responsibility for building futures-thinking capabilities and confidence of young people to navigate the future. Our interactive and immersive experiences around science, technology, design and innovation enable informal learning, integrate arts and creativity, and promote engagement with science and emerging technologies.

​

ZEISS PhotoFusion X Team

Mr Simon Holtmann, Mr Andrew Lanyon, Dr Fang Chen, Ms Nicole Kitchin, Dr Scott Clafton.

​

ZEISS Vision Care 

 

ZEISS PhotoFusion X is a new market-leading photochromic eyeglass lens portfolio from ZEISS Vision Care in the Tonsley Innovation Precinct. ZEISS PhotoFusion X lenses offer market leading speeds for darkening in response to bright light when outdoors, and fade back to clear when returning indoors, without compromising indoor clarity or sunglass level activation. ZEISS PhotoFusion X ensures complete UV protection in all conditions and superior blue light protection.

​

To achieve this, ZEISS PhotoFusion X has leveraged a sustained long-term strategy of market shaping innovations, including ZEISS UVProtect, ZEISS BluePro, and the development of new category-defining photochromic technology. These functions yield a unique product that puts the convenience, comfort, health, and well-being of the consumer at the forefront of the design.

​

ZEISS PhotoFusion X was developed here in South Australia, shaped by our climate and environmental conditions, and therefore meets the needs and sensitivities of Australian consumers. The result is a product full of features that are appreciated around the world, as measured by its commercial success, and recognition through international industry awards.